Companies
Mizuho slashes price target on Intra-Cellular Therapies Inc [ITCI] – find out why.
Intra-Cellular Therapies Inc [NASDAQ: ITCI] stock went on a downward path that fall over -0.04% on Tuesday, amounting to a one-week price increase of more than 0.13%. Over the last 12 months, ITCI stock rose by 90.56%. The one-year Intra-Cellular Therapies Inc stock forecast points